Myosin light chain kinase is a potential target for hypopharyngeal cancer treatment
Hypopharyngeal cancer is squamous cell carcinoma (SCC) with the worst prognosis among the head and neck cancers. Overall, the 5-year survival rate remains poor although diagnostic imaging, radiation, chemotherapy, and surgical techniques have been improved. The mortality of patients with hypopharyng...
Main Authors: | Feng Cao, Le Zhu, Jing Zhang, Pawin Pongkorpsakol, Wei-Ting Kuo, Jerrold R. Turner, Qing Zhou, Yuan Wang, Feihu Chen, Yehai Liu, Li Zuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220308581 |
Similar Items
-
Critical role for the lung endothelial nonmuscle myosin light-chain kinase isoform in the severity of inflammatory murine lung injury
by: Bermudez, T., et al.
Published: (2022) -
Activation of endothelial pro-resolving anti-inflammatory pathways by circulating microvesicles from non-muscular myosin light chain kinase-deficient mice
by: Abderahim Gaceb, et al.
Published: (2016-09-01) -
Distinct Roles of Smooth Muscle and Non-muscle Myosin Light Chain-Mediated Smooth Muscle Contraction
by: Jie Sun, et al.
Published: (2020-12-01) -
Surgically-Treated Locoregionally Advanced Hypopharyngeal Cancer: Outcomes
by: Jorge Rodrigues, et al.
Published: (2018-07-01) -
Transoral robotic resection of a posterior hypopharyngeal wall liposarcoma: A case report of a rare entity and literature review
by: Peter Filip, et al.
Published: (2020-06-01)